Thymoma-A clinico-pathological long-term study with emphasis on histology and adjuvant radiotherapy dose

Journal of Thoracic Oncology

Volumn 7, Issue 12, 2012, Pages 1867-1871

  Harnath, Thomas ^a   Marx, Alexander ^b   Ströbel, Philipp ^b   Bölke, Edwin ^a   Willers, Reinhart ^a   Gripp, Stephan ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adjuvant thymoma pathology; Dose; Multivariate analysis; Myasthenia gravis; Radiotherapy; Retrospective studies; Thymic epithelial tumors

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MYASTHENIA GRAVIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RELAPSE; THYMOMA; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYMUS NEOPLASMS; TIME FACTORS; YOUNG ADULT;

EID: 84870308973     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182745f73     Document Type: Article

References (43)

1. Engels EA, Pfeiffer RM. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 2003;105:546-551. (Pubitemid 36578561)
2. Korst RJ, Kansler AL, Christos PJ, Mandal S. Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis. Ann Thorac Surg 2009;87:1641-1647.
3. Travis WD. Pathology of pulmonary vasculitis. Semin Respir Crit Care Med 2004;25:475-482. (Pubitemid 39518244)
4. Ströbel P, Bauer A, Puppe B, et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol 2004;22:1501-1509. (Pubitemid 41103633)
5. Chen G, Marx A, Chen WH, et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 2002;95:420-429. (Pubitemid 34787609)
6. Yamakawa Y, Masaoka A, Hashimoto T, et al. A tentative tumor-node-metastasis classification of thymoma. Cancer 1991;68:1984-1987.
7. Detterbeck FC. Evaluation and treatment of stage I and II thymoma. J Thorac Oncol 2010;5(10 Suppl 4):S318-S322.
8. Ruffini E, Mancuso M, Oliaro A, et al. Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg 1997;113:55-63. (Pubitemid 27034342)
9. Rosai J. Histological typing of tumours of the thymus. WHO International histological classification of tumours. Berlin: Springer-Verlag, 1999: 5-15.
10. Müller-Hermelink HK, Marino M, Palestro G, Schumacher U, Kirchner T. Immunohistological evidences of cortical and medullary differentiation in thymoma. Virchows Arch A Pathol Anat Histopathol 1985;408:143-161. (Pubitemid 16174495)
11. Kirchner T, Schalke B, Buchwald J, Ritter M, Marx A, Müller- Hermelink HK. Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol 1992;16:1153-1169. (Pubitemid 23004422)
12. Detterbeck FC. Clinical value of the WHO classification system of thymoma. Ann Thorac Surg 2006;81:2328-2334. (Pubitemid 43775600)
13. Suster S, Moran CA. Thymoma classification: current status and future trends. Am J Clin Pathol 2006;125:542-554.
14. Okumura M, Ohta M, Miyoshi S, et al. Oncological significance of WHO histological thymoma classification. A clinical study based on 286 patients. Jpn J Thorac Cardiovasc Surg 2002;50:189-194. (Pubitemid 38166175)
15. Ströbel P, Hohenberger P, Marx A. Thymoma and thymic carcinoma: molecular pathology and targeted therapy. J Thorac Oncol 2010;5(10 Suppl 4):S286-S290.
16. Inoue M, Starostik P, Zettl A, et al. Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas. Cancer Res 2003;63:3708-3715. (Pubitemid 36793056)
17. Zettl A, Ströbel P, Wagner K, et al. Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol 2000;157:257-266. (Pubitemid 30642585)
18. Lardinois D, Rechsteiner R, Läng RH, et al. Prognostic relevance of Masaoka and Müller-Hermelink classification in patients with thymic tumors. Ann Thorac Surg 2000;69:1550-1555. (Pubitemid 30434891)
19. Rena O, Papalia E, Maggi G, et al. World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer 2005;50:59-66. (Pubitemid 41297470)
20. Marchevsky AM, Gupta R, McKenna RJ, et al. Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma. Cancer 2008;112:2780-2788. (Pubitemid 351969224)
21. Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 2002;94:624-632. (Pubitemid 34132289)
22. Utsumi T, Shiono H, Kadota Y, et al. Postoperative radiation therapy after complete resection of thymoma has little impact on survival. Cancer 2009;115:5413-5420.
23. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003;76:878-84; discussion 884. (Pubitemid 37100765)
24. Gupta R, Marchevsky AM, McKenna RJ, et al. Evidence-based pathology and the pathologic evaluation of thymomas: transcapsular invasion is not a significant prognostic feature. Arch Pathol Lab Med 2008;132:926-930. (Pubitemid 351918697)
25. Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg 2004;77:1860-1869. (Pubitemid 38530055)
26. Tormoehlen LM, Pascuzzi RM. Thymoma, myasthenia gravis, and other paraneoplastic syndromes. Hematol Oncol Clin North Am 2008;22:509-526. (Pubitemid 351726408)
27. Batata MA, Martini N, Huvos AG, Aguilar RI, Beattie EJ Jr. Thymomas: clinicopathologic features, therapy, and prognosis. Cancer 1974;34:389-396.
28. Onuki T, Ishikawa S, Yamamoto T, et al. Pathologic radioresponse of preoperatively irradiated invasive thymomas. J Thorac Oncol 2008;3:270-276. (Pubitemid 351654327)
29. Nakahara K, Ohno K, Hashimoto J, et al. Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg 1988;95:1041-1047.
30. Berman AT, Litzky L, Livolsi V, et al. Adjuvant radiotherapy for completely resected stage 2 thymoma. Cancer 2011;117:3502-3508.
31. Forquer JA, Rong N, Fakiris AJ, Loehrer PJ Sr, Johnstone PA. Postoperative radiotherapy after surgical resection of thymoma: differing roles in localized and regional disease. Int J Radiat Oncol Biol Phys 2010;76:440-445.
32. Singhal S, Shrager JB, Rosenthal DI, LiVolsi VA, Kaiser LR. Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg 2003;76:1635-41.
33. Zhang H, Lu N, Wang M, Gu X, Zhang D. Postoperative radiotherapy for stage I thymoma: a prospective randomized trial in 29 cases. Chin Med J 1999;112:136-138.
34. Ruffini E, Van Raemdonck D, Detterbeck F, Rocco G, Thomas P, Venuta F; European Society of Thoracic Surgeons Thymic Questionnaire Working Group. Management of thymic tumors: a survey of current practice among members of the European Society of Thoracic Surgeons. J Thorac Oncol 2011;6:614-623.
35. Ciernik IF, Meier U, Lütolf UM. Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy. J Clin Oncol 1994;12:1484-1490. (Pubitemid 24206249)
36. Urgesi A, Monetti U, Rossi G, Ricardi U, Casadio C. Role of radiation therapy in locally advanced thymoma. Radiother Oncol 1990;19:273-280. (Pubitemid 20369221)
37. Gripp S, Hilgers K, Wurm R, Schmitt G. Thymoma: prognostic factors and treatment outcomes. Cancer 1998;83:1495-1503. (Pubitemid 28465467)
38. Eng TY, Thomas CR Jr. Radiation therapy in the management of thymic tumors. Semin Thorac Cardiovasc Surg 2005;17:32-40. (Pubitemid 40521328)
39. Zhu G, He S, Fu X, Jiang G, Liu T. Radiotherapy and prognostic factors for thymoma: a retrospective study of 175 patients. Int J Radiat Oncol Biol Phys 2004;60:1113-1119. (Pubitemid 39440796)
40. Ogawa K, Uno T, Toita T, et al. Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients. Cancer 2002;94:1405-1413. (Pubitemid 34212633)
41. Kundel Y, Yellin A, Popovtzer A, et al. Adjuvant radiotherapy for thymic epithelial tumor: treatment results and prognostic factors. Am J Clin Oncol 2007;30:389-394. (Pubitemid 47356683)
42. Weksler B, Nason KS, Mackey D, Gallagher A, Pennathur A. Thymomas and extrathymic cancers. Ann Thorac Surg 2012;93:884-888.
43. Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol 2010;5(Suppl 4):S260-S265.